Combination therapy with anti-mediator drugs in allergic disease
- 1 January 2001
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 31 (1) , 11-17
- https://doi.org/10.1046/j.1365-2222.2001.01016.x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitisClinical and Experimental Allergy, 2001
- Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flowClinical and Experimental Allergy, 2000
- Successful treatment of chronic urticaria with leukotriene antagonistsJournal of Allergy and Clinical Immunology, 1998
- Urinary excretion of inflammatory mediators during allergen‐induced early and late phase asthmatic reactionsClinical and Experimental Allergy, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.Thorax, 1996
- Origin of late phase histamine releaseJournal of Allergy and Clinical Immunology, 1996
- PAF and asthma-time for an appraisal?Clinical and Experimental Allergy, 1995
- Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.Thorax, 1987
- Accumulation of leukotriene C4 and histamine in human allergic skin reactions.Journal of Clinical Investigation, 1985